Impact of Anti-CD20 Therapies on Cytokine, Chemokine and Adhesion Molecule Dynamics in Multiple Sclerosis: A Narrative Review. [PDF]
Messner M +5 more
europepmc +1 more source
Bivalent aptamer assemblies: A versatile toolkit for precision targeting of B-cell malignancies. [PDF]
Yin L.
europepmc +1 more source
Immune cells and rheumatic heart disease: A 2-sample and Bayesian weighted Mendelian randomization study. [PDF]
Xue S, Jiang H, Liu C, Zhou Y.
europepmc +1 more source
Therapeutic Antibodies in Hematology: Advances in Malignant and Non-Malignant Disorders. [PDF]
Yasui H, Idogawa M, Ishida T, Imai K.
europepmc +1 more source
Aberrant B cell responses as drivers of autoantibody generation and epitope diversification in SLE pathogenesis. [PDF]
Tariq F +3 more
europepmc +1 more source
Research Advances in Rituximab-Resistant Membranous Nephropathy. [PDF]
Li K, Liu W, Wu D, Su Z, Wan Q.
europepmc +1 more source
A Customizable Tyramide Signal Amplification-Based Multiplex Immunofluorescence Protocol for FFPE Tissues. [PDF]
Sheng W +8 more
europepmc +1 more source
Viral associations in multiple sclerosis: pathogenetic mechanisms and therapeutic implications. [PDF]
Meshref M +5 more
europepmc +1 more source
Targeting the CD47/SIRPα interaction in cancer: opportunities in non-Hodgkin lymphoma. [PDF]
Pagès-Geli C, Weiskopf K.
europepmc +1 more source
AI-guided CAR designs and targeted pathway modulation to enhance multi-antigen CAR T cell durability and overcome antigen escape. [PDF]
Ansari MS +32 more
europepmc +1 more source

